# EDGAR Filing Document

**Accession Number:** 0001843249
**File Stem:** 0001213900-23-020692
**Filing Date:** 2023-3
**Character Count:** 10409
**Document Hash:** a7aaaa983f2d41d1a53d09f13cbb2714
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001213900-23-020692.hdr.sgml**: 20230317

**ACCESSION NUMBER**: 0001213900-23-020692

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 14

**CONFORMED PERIOD OF REPORT**: 20230316

**ITEM INFORMATION**: Other Events

**ITEM INFORMATION**: Financial Statements and Exhibits

**FILED AS OF DATE**: 20230317

**DATE AS OF CHANGE**: 20230316

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Northern Genesis Acquisition Corp. III
- **CENTRAL INDEX KEY:** 0001843249
- **STANDARD INDUSTRIAL CLASSIFICATION:** BLANK CHECKS [6770]
- **IRS NUMBER:** 000000000
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-40269
- **FILM NUMBER:** 23740217

**BUSINESS ADDRESS:**
- **STREET 1:** 4801 MAIN STREET
- **STREET 2:** SUITE 1000
- **CITY:** KANSAS CITY
- **STATE:** MO
- **ZIP:** 64112
- **BUSINESS PHONE:** 816-514-0324

**MAIL ADDRESS:**
- **STREET 1:** 4801 MAIN STREET
- **STREET 2:** SUITE 1000
- **CITY:** KANSAS CITY
- **STATE:** MO
- **ZIP:** 64112

?xml version="1.0" encoding="utf-8"?

**UNITED STATES SECURITIES AND EXCHANGE COMMISSION**

**Washington**, **D.C. 20549**

**FORM 8-K**

**CURRENT REPORT**

**Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934**

Date of report (Date of earliest event reported): March 16, 2023

**NORTHERN GENESIS ACQUISITION CORP. III**

(Exact Name of Registrant as Specified in Charter)

---

| | | |
|:---|:---|:---|
| **Delaware** | **001-39881** | **86-1484719** |
| (State of incorporation<br> or organization) | (Commission File Number) | (I.R.S. Employer <br> Identification Number) |

---

---

| | |
|:---|:---|
| **4801 Main Street, Suite 1000**<br> **Kansas City, MO** | **64112** |
| (Address of principal executive offices) | (Zip Code) |

---

**(816) 514-0324**

(Registrant's telephone number, including area code)

**Not Applicable**

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the Registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| **Title of each class** | **Trading symbol(s)** | **Name of each exchange on which registered** |
| Units, each consisting of one share of common stock and one-quarter of one redeemable warrant | NGC.U | New York Stock Exchange |
| Common Stock, par value $0.0001 per share | NGC | New York Stock Exchange |
| Warrants, each whole warrant exercisable for one share of common stock at an exercise price of $11.50 per share | NGC.WS | New York Stock Exchange |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

**Item 8.01. Other Events.**

On March 16, 2023, Northern Genesis Acquisition Corp. III (the "Company") issued a press release announcing that it will redeem all of its outstanding shares of common stock that were included in the units issued in its initial public offering (the "public shares"), effective as of the close of business on March 27, 2023, as the Company will not consummate an initial business combination within the time period required by its Amended and Restated Certificate of Incorporation. A copy of the press release is included as Exhibit 99.1 to this Current Report on Form 8-K (this "Current Report") and is incorporated herein by reference.

**<u>Cautionary Statements Regarding Forward-Looking Statements</u>**

This Current Report includes "forward-looking statements" within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements relate to expectations or forecasts for future events, including, without limitation, the redemption of the Company's public shares and the Company's subsequent dissolution and liquidation and its delisting from the New York Stock Exchange and its termination of registration with the Commission. Certain of these forward-looking statements can be identified by the use of words such as "believes," "expects," "intends," "plans," "estimates," "assumes," "may," "should," "will," "seeks," or other similar expressions. These statements are based on current expectations on the date of this Current Report and involve a number of risks and uncertainties that may cause actual results to differ significantly. The Company does not assume any obligation to update or revise any such forward-looking statements, whether as the result of new developments or otherwise. Readers are cautioned not to put undue reliance on forward-looking statements.

**Item 9.01. Financial Statements and Exhibits.**

(d) Exhibits.

---

| | |
|:---|:---|
| **Exhibit No.** | **Description of Exhibit** |
| 99.1 | [Press Release, dated March 16, 2023](ea175355ex99-1_northerngen3.htm) |
| 104 | Cover Page Interactive Data file (embedded within the inline XBRL document) |

---

**SIGNATURE**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.

Dated: March 16, 2023

---

| | | |
|:---|:---|:---|
| NORTHERN GENESIS ACQUISITION CORP. III | NORTHERN GENESIS ACQUISITION CORP. III | NORTHERN GENESIS ACQUISITION CORP. III |
| By: | /s/ Michael Hoffman | /s/ Michael Hoffman |
|  | Name: | Michael Hoffman |
|  | Title: | President |

---

## Exhibit 99.1

**Exhibit 99.1**

**Northern Genesis Acquisition Corp. III Announces Redemption of Public Shares and Subsequent Dissolution**

Kansas City, MO, March 16, 2023 (GLOBE NEWSWIRE) -- Northern Genesis Acquisition Corp. III (the "Company") (NYSE: NGC.U; NGC; NGC.WS) today announced that it will redeem all of its outstanding shares of common stock that were included in the units issued in its initial public offering (the "public shares"), effective as of the close of business on March 27, 2023, as the Company will not consummate an initial business combination within the time period required by its Amended and Restated Certificate of Incorporation (the "Charter").

Pursuant to its Charter, if the Company does not complete its initial business combination by March 26, 2023, then the Company will: (i) cease all operations except for the purpose of winding up, (ii) redeem the public shares within ten business days thereafter, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Company's trust account including interest earned on the funds held in the trust account (less permitted deductions), divided by the number of then outstanding public shares, which redemption will completely extinguish public shareholders' rights as shareholders (including the right to receive further liquidation distributions, if any), subject to applicable law, and (iii) thereafter, subject to the approval of the Company's remaining shareholders and its board of directors, dissolve and liquidate, subject in each case to the Company's obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law.

The per-share redemption price for the public shares will be approximately $10.15.

The public shares will cease trading as of the close of business on March 24, 2023. As of the close of business on March 27, 2023, the public shares will be deemed cancelled and will represent only the right to receive the redemption amount.

The redemption amount will be payable to the holders of the public shares upon delivery of their shares or units. Beneficial owners of public shares held in "street name," however, will not need to take any action in order to receive the redemption amount.

There will be no redemption rights or liquidating distributions with respect to the Company's warrants, which will expire worthless.

The Company expects that the New York Stock Exchange will file a Form 25 with the United States Securities and Exchange Commission (the "Commission") to delist the Company's securities. The Company thereafter expects to file a Form 15 with the Commission to terminate the registration of its securities under the Securities Exchange Act of 1934, as amended.

**<u>Cautionary Statements Regarding Forward-Looking Statements</u>**

This Current Report on Form 8-K includes "forward-looking statements" within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements relate to expectations or forecasts for future events, including, without limitation, the redemption of the Company's public shares and the Company's subsequent dissolution and liquidation and its delisting from the New York Stock Exchange and its termination of registration with the Commission. Certain of these forward-looking statements can be identified by the use of words such as "believes," "expects," "intends," "plans," "estimates," "assumes," "may," "should," "will," "seeks," or other similar expressions. These statements are based on current expectations on the date of this Form 8-K and involve a number of risks and uncertainties that may cause actual results to differ significantly. The Company does not assume any obligation to update or revise any such forward-looking statements, whether as the result of new developments or otherwise. Readers are cautioned not to put undue reliance on forward-looking statements.

Investor Relations<br> Investors@northerngenesis.com<br> 816-514-0324